The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Severe Hypoglycemia and Risks of Vascular Events and Death
Open accessAbstract
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes. METHODS: We examined the associations between severe hypoglycemia and the risks of macrovascular or microvascular events and death among 11,140 patients with type 2 diabetes, using Cox proportional-hazards models with adjustment for covariates measured at baseline and after randomization. RESULTS: During a median follow-up period of 5 years, 231 patients (2.1%) had at least one severe hypoglycemic episode; 150 had been assigned to intensive glucose control (2.7% of the 5571 patients in that group), and 81 had been assigned to standard glucose control (1.5% of the 5569 patients in that group). The median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years (interquartile range, 0.84 to 2.41), 0.99 years (interquartile range, 0.40 to 2.17), and 1.05 years (interquartile range, 0.34 to 2.41), respectively. During follow-up, severe hypoglycemia was associated with a significant increase in the adjusted risks of major macrovascular events (hazard ratio, 2.88; 95% confidence interval [CI], 2.01 to 4.12), major microvascular events (hazard ratio, 1.81; 95% CI, 1.19 to 2.74), death from a cardiovascular cause (hazard ratio, 2.68; 95% CI, 1.72 to 4.19), and death from any cause (hazard ratio, 2.69; 95% CI, 1.97 to 3.67) (P<0.001 for all comparisons). Similar associations were apparent for a range of nonvascular outcomes, including respiratory, digestive, and skin conditions (P<0.01 for all comparisons). No relationship was found between repeated episodes of severe hypoglycemia and vascular outcomes or death. CONCLUSIONS: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes. It is possible that severe hypoglycemia contributes to adverse outcomes, but these analyses indicate that hypoglycemia is just as likely to be a marker of vulnerability to such events. (Funded by Servier and the National Health and Medical Research Council of Australia; ClinicalTrials.gov number, NCT00145925.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the frequency of severe hypoglycemia in these trials was 2 to 3 times higher in the intensive therapy groups”
From Targets for Glycemic Control (2018) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with type 2 diabetes and established, or very high risk for, cardiovascular disease (CVD), there is a clear association between an increased mortality and severe hypoglycemia (62,63) and symptomatic hypoglycemia (64).”
From Hypoglycemia (2018) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Post hoc analysis of clinical trials examining the effects of strict glycemic control on cardiovascular outcomes showed that exposure to severe hypoglycemia was strongly associated with a range of adverse outcomes, including death (2, 3).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
The cited source says what the claim attributes to it.
In the citing paper
“a higher mortality was reported in participants with 1 or more episodes of severe hypoglycemia in the ACCORD (30), ADVANCE (31) and VADT trials (25), irrespective of the different treatment arms in which individual participants were allocated.”
From Targets for Glycemic Control (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [77]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“U500 regular insulin (contains 500 units/mL of regular insulin) may improve glycemia in the therapy of persons with DM who have severe insulin resistance (eg, require >200 total units of insulin/day).1102–1105”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1105]
Experimental — accuracy not yet measuredIn the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [197]
In the citing paper
“All three trials clearly demonstrated that an episode of severe hypoglycemia was associated with an increased risk of subsequent mortality.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial (90).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
Patel, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61303-8 · Cited by 2,054
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Self-citationGerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Flagged first, then by citations
Research works printed but not linked: 3
- Therneau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer, 2000.
- Hoekstra JBL, 2009, Diabetologia, 52, 237
- Miller ME, 2009, Diabetologia, 52, 63
Cited by
Sorted by citations
Items 501–600 of 1,002
Environmental Signals Influencing Myeloid Cell Metabolism and Function in Diabetes
Ratter, J. M., Tack, C. J., Netea, M. G., & Stienstra, R. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.04.008 · Cited by 27
May, M., Framke, T., Junker, B., Framme, C., Pielen, A., & Schindler, C. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819891886 · Cited by 27
Kong, A. P. S., Lew, T., Lau, E. S. H., Lim, L., Kesavadev, J., Jia, W., Sheu, W. H., Sobrepeña, L., Tan, A. T. B., Nguyen, T. K., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13950 · Cited by 28
Haukka, J. K., Hoti, F. J., Erästö, P., Saukkonen, T. T., Mäkimattila, S., & Korhonen, P. A. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3534 · Cited by 26
Leong, A., Berkowitz, S. A., Triant, V. A., Porneala, B., He, W. W., Atlas, S. J., Wexler, D. J., & Meigs, J. B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3169 · Cited by 26
Emergency treatment of hypoglycaemia: a guideline and evidence review
Villani, M., de Courten, B. V., & Zoungas, S. (2017) · Diabetic Medicine · doi:10.1111/dme.13379 · Cited by 26
Self-citationGupta, A. K. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190425182008 · Cited by 26
Treating diabetes today with gliclazide MR: a matter of numbers
Avogaro, A. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01508.x · Cited by 26
Gitt, A. K., Bramlage, P., Binz, C., Krekler, M., Plate, T., Deeg, E., Tschöpe, D., & (for the DiaRegis Study Group) (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711411104 · Cited by 26
Roumie, C. L., Min, J. Y., Greevy, R. A., Grijalva, C. G., Hung, A. M., Liu, X., Elasy, T. A., & Griffin, M. R. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.150904 · Cited by 26
Villani, M., Nanayakkara, N., Ranasinha, S., Tan, C. Y., Smith, K. L., Morgans, A., Soldatos, G., Teede, H. J., & Zoungas, S. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.04.015 · Cited by 26
Self-citationBaroreflex sensitivity impairment during hypoglycemia: implications for cardiovascular control
Rao, A. D., Bonyhay, I., Dankwa, J., Baimas-George, M., Kneen, L., Ballatori, S., Freeman, R., & Adler, G. K. (2016) · Diabetes · doi:10.2337/db15-0871 · Cited by 25
Miura, H., Sakaguchi, K., Otowa‐Suematsu, N., Yamada, T., So, A., Komada, H., Okada, Y., Hirota, Y., Tamori, Y., & Ogawa, W. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14161 · Cited by 25
Tabesh, M., Sacre, J. W., Mehta, K., Chen, L., Sajjadi, S. F., Magliano, D. J., & Shaw, J. E. (2025) · Diabetic Medicine · doi:10.1111/dme.70123 · Cited by 25
Hypoglycemia and Comorbidities in Type 2 Diabetes
Kong, A. P. S., & Chan, J. C. N. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0646-x · Cited by 30
Rodríguez‐Gutiérrez, R., Ospina, N. S., McCoy, R. G., Lipska, K. J., Shah, N. D., Montori, V. M., & for the Hypoglycemia as a Quality Measure in Diabetes Study Group (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5046 · Cited by 25
Direct-to-consumer strategies to promote deprescribing in primary care: a pilot study
Linsky, A. M., Kressin, N. R., Stolzmann, K. L., Pendergast, J. N., Rosen, A. K., Bokhour, B. G., & Simon, S. R. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01655-5 · Cited by 26
Kilpatrick, E. S., Rigby, A. S., Atkin, S. L., & Frier, B. M. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03612.x · Cited by 25
Soydan, N., Bretzel, R. G., Fischer, B., Wagenlehner, F., Pilatz, A. M. E., & Linn, T. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.003 · Cited by 26
Britton, K. A., Aggarwal, V., Chen, A. Y., Alexander, K. P., Amsterdam, E. A., Fraulo, E. S., Muntner, P., Thomas, L. E., McGuire, D. K., Wiviott, S. D., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.12.004 · Cited by 25
Bonora, E., & CIGOLINI, M. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.03.002 · Cited by 25
Hypoglycemia Patients and Transport by EMS in Alameda County, 2013–15
Moffet, H. H., Warton, E. M., Siegel, L., Sporer, K. A., Lipska, K. J., & Karter, A. J. (2017) · Prehospital Emergency Care · doi:10.1080/10903127.2017.1321707 · Cited by 25
Kalyani, R. R., Allende-Vigo, M. Z., Antinori-Lent, K. J., Close, K. L., Das, S. R., Deroze, P., Edelman, S. V., El Sayed, N. A., Kerr, D., Neumiller, J. J., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad745 · Cited by 25
Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes
Yun, J., Ko, S., Ko, S.-H., Song, K., Yoo, K., Yoon, K., Park, Y., & Ahn, Y. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.6.498 · Cited by 24
Chiang, H.-H., Tseng, F., Wang, C., Chen, C., Chen, Y., See, T.-T., & Chen, H.-F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109501 · Cited by 24
Shi, C., Liu, S., Yu, H., & Han, B. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107549 · Cited by 24
Lee, J., Kim, Y., Han, K., Han, E., Lee, B., Kang, E. S., Soo, B., Ko, S., & Lee, Y. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0262 · Cited by 24
Parsaik, A. K., Carter, R. E., Myers, L. A., Basu, A., & Kudva, Y. C. (2012) · Endocrine Practice · doi:10.4158/ep12197.or · Cited by 24
Vimalananda, V. G., DeSotto, K., Chen, T., Mullakary, J., Schlosser, J. E., Archambeault, C., Peck, J. S., Cassidy, H., Conlin, P. R., Evans, S., et al. (2017) · Diabetes Spectrum · doi:10.2337/ds16-0006 · Cited by 24
Rhyu, Y. A., Jang, J.-Y., Park, S., An, J. H., Kim, D., Kim, S. K., & Song, K. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.2.187 · Cited by 24
Low HbA1c and mortality: causation and confounding
Rutter, M. K. (2012) · Diabetologia · doi:10.1007/s00125-012-2620-3 · Cited by 24
Maddaloni, E., & Pozzilli, P. (2013) · Endocrine · doi:10.1007/s12020-013-0128-3 · Cited by 24
Approaches to risk assessment among older patients with diabetes
Pilla, S. J., Schoenborn, N. L., Maruthur, N. M., & Huang, E. S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1172-z · Cited by 24
Hypoglycemia communication in primary care visits for patients with diabetes
Pilla, S. J., Park, J., Schwartz, J. L., Albert, M. C., Ephraim, P. L., Boulware, L. E., Mathioudakis, N. N., Maruthur, N. M., Beach, M. C., & Greer, R. C. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06385-x · Cited by 23
Gore, M. O., & McGuire, D. K. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr019 · Cited by 23
Funamizu, T., Iwata, H., Nishida, Y., Miyosawa, K., Doi, S., Chikata, Y., Shitara, J., Endo, H., Wada, H., Naito, R., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-00996-8 · Cited by 23
Davies, M. J., Bianchi, C., & Prato, S. D. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154242 · Cited by 24
Rooney, M. R., Tang, O., Echouffo-Tcheugui, J. B., Lutsey, P. L., Grams, M. E., Windham, B. G., & Selvin, E. (2021) · Diabetes Care · doi:10.2337/dc20-3045 · Cited by 24
Bahrami, J., TOMLINSON, G. A., Murphy, H. R., Feig, D. S., & the CONCEPTT Collaborative Group (2022) · Diabetic Medicine · doi:10.1111/dme.14789 · Cited by 23
Humos, B., Mahfoud, Z. R., Dargham, S. R., Suwaidi, J. M. S. A., Jneid, H. M., & Khalil, C. A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.940035 · Cited by 24
Geographic variation in pharmacotherapy decisions for U.S. medicare enrollees with diabetes
Sargen, M. R., Hoffstad, O., Wiebe, D. J., & Margolis, D. J. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.04.001 · Cited by 23
How Important is Glycemic Control During Coronary Artery Bypass?
Lazar, H. L. (2012) · Advances in Surgery · doi:10.1016/j.yasu.2012.03.007 · Cited by 23
Mezquita‐Raya, P., Reyes‐García, R., Moreno, Ó., Muñoz‐Torres, M., Merino-Torres, J. F., Martínez, J. J. G., Jódar-Gimeno, E., Escalada, J., Gargallo-Fernández, M., Soto-González, A., et al. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.04.005 · Cited by 23
Risk of hospitalization for hypoglycemia among older Korean people with diabetes mellitus
Kim, H. M., Seong, J.-M., & Kim, J. (2016) · Medicine · doi:10.1097/md.0000000000005016 · Cited by 23
Wysham, C., Campos, C., & Kruger, D. F. (2018) · Clinical Diabetes · doi:10.2337/cd17-0064 · Cited by 23
Núñez, M., Díaz‐Cerezo, S., Dilla, T., Reviriego, J., & Pérez, A. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0563-0 · Cited by 23
Targets for blood glucose: What have the trials told us
Valensi, P. E., Prévost, G., Schnell, O., Standl, E., & Ceriello, A. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319885456 · Cited by 23
Diabetic vascular disease and the potential role of macrophage glucose metabolism
Nishizawa, T., & Bornfeldt, K. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.585346 · Cited by 24
Tsujimoto, T., Yamamoto‐Honda, R., Kajio, H., Kishimoto, M., Noto, H., Hachiya, R., Kimura, A., Kakei, M., & Noda, M. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1017528 · Cited by 23
Klempfner, R., Elis, A., Matezky, S., Keren, G., Roth, A., Finkelstein, A., Banai, S., Goldenberg, I., Fisman, E. Z., Tenenbaum, A., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.116 · Cited by 22
Li, G., Zhong, S., Wang, X., & Zhuge, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1222409 · Cited by 23
Hospitalization for Hypoglycemia in Japanese Diabetic Patients
Sako, A., Yasunaga, H., Matsui, H., Fushimi, K., Hamasaki, H., Katsuyama, H., Tsujimoto, T., Goto, A., & Yanai, H. (2015) · Medicine · doi:10.1097/md.0000000000001029 · Cited by 22
Intensive Glycemic Control and Renal Outcome
Jun, M., Perkovic, V., & Cass, A. (2011) · Contributions to nephrology · doi:10.1159/000325664 · Cited by 22
Personalizing guidelines for diabetes management: twilight or dawn of the expert?
Paschou, S. Α., & Leslie, R. D. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-161 · Cited by 22
Yu, H.-C., Tsai, W., & Kung, P. (2013) · Health Policy and Planning · doi:10.1093/heapol/czt056 · Cited by 22
Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6
An, X., Li, L., Chen, Y., Luo, A., Ni, Z., Liu, J., Yuan, Y., Shi, M., Chen, B., Long, D., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040483 · Cited by 22
Zhao, Y., Shi, Q., Wang, Y., Fonseca, V. A., & Shi, L. (2016) · Journal of Medical Economics · doi:10.1080/13696998.2016.1178126 · Cited by 22
Zhong, V. W., Juhaeri, J., Cole, S. R., Shay, C. M., Gordon‐Larsen, P., Kontopantelis, E., & Mayer‐Davis, E. J. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.10.008 · Cited by 22
Liu, L., Liu, J., Xu, L., Ke, W., Wan, X., Li, H., He, X., Wang, L., Cao, X., Xiao, H., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12782 · Cited by 24
Chiang, C., Lin, S.-Y., Lin, T., Wang, T., Yeh, H., Chen, J., Tsai, C., Hung, Y.-J., Li, Y., Liu, P., et al. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.01.001 · Cited by 22
Escalada, J., Halimi, S., Senior, P. A., Bonnemaire, M., Cali, A. M. G., Melas‐Melt, L., Karalliedde, J. J., & Ritzel, R. A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13470 · Cited by 22
Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD
Chow, L. S., Chen, H., Miller, M. E., Marcovina, S. M., & Seaquist, E. R. (2015) · Diabetologia · doi:10.1007/s00125-015-3512-0 · Cited by 22
Endocrine and metabolic emergencies: hypoglycaemia
Mukherjee, E., Carroll, R. W., & Matfin, G. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018811401644 · Cited by 23
Wan, E. Y. F., Fong, D., Fung, C. S. C., & Lam, C. L. K. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.010 · Cited by 22
Sreenan, S., Andersen, M., Thorsted, B. L., Wolden, M. L., & Evans, M. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0075-x · Cited by 21
Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes
Mahoney, G. K., Henk, H. J., & McCoy, R. G. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.02.028 · Cited by 21
How Significant Is Severe Hypoglycemia in Older Adults With Diabetes?
Chow, L. S., & Seaquist, E. R. (2020) · Diabetes Care · doi:10.2337/dci19-0069 · Cited by 21
Pharmacogenetics of hypoglycemia associated with sulfonylurea therapy in usual clinical care
Mitchell, S. L., Leon, D. A. C., Chaugai, S., Kawai, V. K., Levinson, R. T., Wei, W., & Stein, C. M. (2020) · The Pharmacogenomics Journal · doi:10.1038/s41397-020-0171-4 · Cited by 21
Fear of hypoglycaemia among patients with type 2 diabetes mellitus: a cross-sectional study
Wang, Y., Zeng, Z., Ding, J., Yuan, R., Wang, R., Zhang, Y., Bai, L., Yu, H., & Tang, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-86954-0 · Cited by 21
The Impact of Hypoglycemia on Patients with Diabetes Mellitus: A Cross-Sectional Analysis
Agrawal, S., Makuch, S., Dróżdż, M., Dudzik, T., Domański, I., Poręba, R., & Mazur, G. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030626 · Cited by 21
Christiaens, A., Baretella, O., Giovane, C. D., Rodondi, N., Knol, W., Peters, M. J. L., Jennings, E., O’Mahony, D., Spinewine, A., Boland, B. B., et al. (2023) · Age and Ageing · doi:10.1093/ageing/afac320 · Cited by 21
Mortality risk with sulphonylureas compared to metformin
Holden, S. E., & Currie, C. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12280 · Cited by 22
The Impact of Current and Novel anti-diabetic Therapies On Cardiovascular Risk
Ussher, J. R., Sutendra, G., & Jaswal, J. S. (2012) · Future Cardiology · doi:10.2217/fca.12.68 · Cited by 21
Davis, T. M. E., Chubb, S. A. P., Bruce, D. G., & Davis, W. A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12655 · Cited by 21
Hypoglycemia During Therapy of Diabetes
Spanakis, E. K., Cryer, P. E., & Davis, S. N. (2015) · Europe PMC (PubMed Central) · Cited by 21
Kanazawa, I., Tanaka, K.-I., Notsu, M., Tanaka, S., Kiyohara, N., Koike, S., Yamane, Y., Tada, Y., Sasaki, M., Yamauchi, M., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.010 · Cited by 21
Liu, L., Chen, X., Liu, Y., Sun, X., Yin, Z., Li, H., Zhang, M., Wang, B., Ren, Y., Zhao, Y., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3129 · Cited by 21
Balla, S. A. (2014) · American Journal of Health Research · doi:10.11648/j.ajhr.20140206.16 · Cited by 21
Pfohl, M., Schädlich, P. K., Dippel, F. W., & Koltermann, K. C. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.713879 · Cited by 21
Hypoglycemia Revisited in the Acute Care Setting
Tsai, S., Lin, Y., Hsu, C.-W., Cheng, C.-S., & Chu, D. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.6.898 · Cited by 22
Monoconjugation of Human Amylin with Methylpolyethyleneglycol
Sisnande, T., Guerreiro, L. H., Braga, R. R., Jotha-Mattos, L., Erthal, L. C. S., Tinoco, P., Ferreira, B. M., & Lima, L. M. T. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138803 · Cited by 21
Advances in the Diagnosis of Coronary Atherosclerosis
Kira, S. F. (2011) · InTech eBooks · doi:10.5772/790 · Cited by 21
Cheng, A. Y. Y., Wong, J., Freemantle, N., Acharya, S. H., & Ekinci, E. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00925-8 · Cited by 20
Glycemia Assessed by Continuous Glucose Monitoring among People Treated with Maintenance Dialysis
de Boer, I. H., Anderson, L. D., Ashford, N. K., Ayers, E., Bansal, N., Hall, Y. N., Hirsch, I. B., Hoofnagle, A. N., Hsu, S., Jones, E., et al. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000693 · Cited by 20
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
Schnell, O., Almandoz, J. P., Anderson, L., Barnard-Kelly, K. D., Battelino, T., Blüher, M., Busetto, L., Catrinou, D., Ceriello, A., Cos, X., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02700-0 · Cited by 21
Omura, T., Tamura, Y., Sakurai, T., Umegaki, H., Iimuro, S., Ohashi, Y., Ito, H., & Araki, A. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14171 · Cited by 20
Karayiannides, S., Norhammar, A., Landstedt‐Hallin, L., Friberg, L., & Lundman, P. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac093 · Cited by 22
Zeng, Z., Wang, X., Chen, Y., Zhou, H., Zhu, W., Xiong, X., Tang, J., & Zhao, Q. (2023) · Health and Quality of Life Outcomes · doi:10.1186/s12955-023-02183-1 · Cited by 20
Hong, A.-R., Lee, J., Ku, E. J., Hwangbo, Y., Kim, K. M., Moon, J. H., Choi, S. H., Jang, H. C., & Lim, S. K. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.019 · Cited by 20
Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes
Donner, T. W., & Joseph, J. J. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s50286 · Cited by 21
Association of Hypoglycemia With Incident Chronic Kidney Disease in Patients With Type 2 Diabetes
Shih, C.-J., Wu, Y.-L., Lo, Y., Kuo, S., Tarng, D., Lin, C., Ou, S., & Chen, Y. (2015) · Medicine · doi:10.1097/md.0000000000000771 · Cited by 20
The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes
Paty, B. W. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.009 · Cited by 21
Santamarina, M. L., & Carlson, C. J. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1036-0 · Cited by 20
Namba, M., Iwakura, T., Nishimura, R., Akazawa, K., Matsuhisa, M., Atsumi, Y., Satoh, J., & Yamauchi, T. (2018) · Diabetology International · doi:10.1007/s13340-018-0346-2 · Cited by 20
Management of chronic kidney disease
Tomson, C., & Bailey, P. (2011) · Medicine · doi:10.1016/j.mpmed.2011.04.006 · Cited by 20
Hsiao, C.-C., Tu, H., Lin, C., Chen, K., Yeh, Y., & See, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040420 · Cited by 20
Pea, F. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.06.006 · Cited by 20
Continuous glucose monitoring in older people with diabetes receiving home care—a feasibility study
Larsen, A. B., Hermann, M., & Graue, M. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00754-3 · Cited by 19
Koška, J., Nuyujukian, D. S., Bahn, G., Zhou, J. J., & Reaven, P. D. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01418-z · Cited by 19
Hegmann, K. T., Andersson, G. B. J., Greenberg, M. I., Phillips, B. A., & Rizzo, M. (2012) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3182480535 · Cited by 19
Metadata
- Authors
- Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Grobbee, D. E., Kengne, A. P., Marre, M., & Heller, S.
- Affiliations
- The University of Sydney (AU)
- University Medical Center Utrecht (NL)
- Hôpital Bichat-Claude-Bernard (FR)
- National Health Service (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1410-1418
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2097995302
- Semantic Scholar
- b73e51368b0f6c3d0c425e6670188db927bc8b09
- Cited by
- 1,471
- References
- 31
- Citations by year
- 2026: 33 · 2025: 49 · 2024: 64 · 2023: 60 · 2022: 66 · 2021: 103 · 2020: 119 · 2019: 99 · 2018: 113 · 2017: 103 · 2016: 107 · 2015: 147 · 2014: 106 · 2013: 98 · 2012: 103
- FWCI
- 71.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe hypoglycemia, type 2 diabetes, tight glycemic control, macrovascular events, cardiovascular mortality, all-cause mortality, adverse clinical outcomes, diabetes complications, UKPDS
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gliclazide, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Risk Factors, Vascular Diseases, Proportional Hazards Models, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
